FMR LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 315066 BOSTON, MA

Position in INO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,250,928

-$882,267 QoQ

Shares Held

9,339,614

-5.1% QoQ

Ownership

11.4%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.99956100969484.ToString("F0")% Shared 0.ToString("F0")% None 0.0004389903051667874.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,674,888,413 across 352 Biotechnology names. INO ranks #136 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,250,928	9,339,614	-5.1%	Shares	Defined	2026-05-15
2025-12-31	$17,133,195	9,846,664	0.0%	Shares	Defined	2026-02-17
2025-11-28	$20,284,127	9,846,664	+756753.5%	Shares	Sole	2025-12-05
2025-09-30	$3,043	1,301	-98.5%	Shares	Defined	2025-11-13
2025-06-30	$178,181	87,344	-13.2%	Shares	Defined	2025-08-14
2025-03-31	$164,099	100,675	+23.7%	Shares	Defined	2025-05-12
2024-12-31	$148,924	81,380	+198.5%	Shares	Defined	2025-02-13
2024-09-30	$157,568	27,261	+370.1%	Shares	Defined	2024-11-13
2024-06-30	$46,855	5,799	-53.3%	Shares	Defined	2024-08-13
2024-03-31	$172,264	12,411	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.